It is well established that the primary modes of altering myocardial contractility on a beat-to-beat basis involve both the modulation of the myoplasmic Ca2+ ([Ca2+]i) availability at the level of the myofilaments (MF), and changes in the Ca2+-response of the MF, especially via length- dependent activation. Alternatively, certain more slowly developing covalent modifications of MF have been recognized (such as thick or thin filament phosphorylation), but these are of uncertain functional significance in cardiac tissue. Hypothesizing that the [Ca2+]i """"""""history"""""""" regulates contractility via such covalent modification, we performed [Ca2+]i-clamp experiments at various levels (ranging up to 10-fold > resting [Ca2+]i) and durations (up to 60s) via 10 hz tetanization in sarcoplasmic reticulum-disabled (thapsigargin or caffeine treated) intact rat cardiac myocytes loaded with indo-1 free acid. We observed that the rising phase of the tetanus (2-3 sec) was sufficiently slow such that Ca2+-MF binding, and thus force and cell length, were throughout at equilibrium, enabling a rapid assessment of baseline contractile activation. A secondary [Ca2+]i- and time-dependent increase in cell shortening was observed despite steady levels of clamped [Ca2+]i, and without significant change in pHi, Mgi or ATPi (as assessed by SNARF and mag-indo-1 loaded cells). This secondary leftward shift in the length-pCa curve was attenuated by the calmodulin inhibitors chlorpromazine, W7, and Sr2+, and by the myosin light chain kinase (MLCK) inhibitor KT5926, and was amplified by the phosphoprotein phosphatase inhibitor Calyculin A. We propose that [Ca2+]i history, via Ca2+-calmodulin-dependent MLCK activity, myosin light chain phosphorylation, and kinase/phosphatase balance, plays a significant modulatory role in the chronic regulation of contractility in intact heart cells. This integrative phenomenon would reflect a history dependence of cardiac work/demand, and may serve as an important cardiovascular adaptive mechanism in myocardial conditioning.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Intramural Research (Z01)
Project #
1Z01AG000261-05
Application #
3789782
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1992
Total Cost
Indirect Cost
Name
National Institute on Aging
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Zahodne, Laura B; Stern, Yaakov; Manly, Jennifer J (2014) Depressive symptoms precede memory decline, but not vice versa, in non-demented older adults. J Am Geriatr Soc 62:130-4
Zorov, Dmitry B; Kobrinsky, Evgeny; Juhaszova, Magdalena et al. (2004) Examining intracellular organelle function using fluorescent probes: from animalcules to quantum dots. Circ Res 95:239-52
Lakatta, Edward G; Sollott, Steven J (2002) Perspectives on mammalian cardiovascular aging: humans to molecules. Comp Biochem Physiol A Mol Integr Physiol 132:699-721
Vila Petroff, M G; Egan, J M; Wang, X et al. (2001) Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. Circ Res 89:445-52
Lakatta, E G; Sollott, S J; Pepe, S (2001) The old heart: operating on the edge. Novartis Found Symp 235:172-96; discussion 196-201, 217
Petroff, M G; Kim, S H; Pepe, S et al. (2001) Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes. Nat Cell Biol 3:867-73
Zorov, D B; Filburn, C R; Klotz, L O et al. (2000) Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med 192:1001-14
Vila-Petroff, M G; Younes, A; Egan, J et al. (1999) Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res 84:1020-31